| Return Create A Forum - Home | |
| --------------------------------------------------------- | |
| MS Speaks | |
| https://msspeaks.createaforum.com | |
| --------------------------------------------------------- | |
| ***************************************************** | |
| Return to: MAVENCLAD (cladribine) | |
| ***************************************************** | |
| #Post#: 2459-------------------------------------------------- | |
| Cladribine (Mavenclad) approved for active SPMS, RRMS | |
| By: agate Date: April 1, 2019, 8:00 pm | |
| --------------------------------------------------------- | |
| Another MS drug has been approved. Like siponimod (Mayzent), it | |
| turns out to be for SPMS only if it's still active SPMS (still | |
| having relapses). From the MSAA (April 1, 2019): | |
| https://mymsaa.org/mavenclad-approved-fda/?utm_source=latest_news&utm_medium=em… | |
| ***************************************************** |